The store will not work correctly when cookies are disabled.
(R)-N-(4-chlorophenyl)-1-(1-phenylethyl)-1H-imidazole-5-carboxamide
ID: ALA4758713
PubChem CID: 162658752
Max Phase: Preclinical
Molecular Formula: C18H16ClN3O
Molecular Weight: 325.80
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: C[C@H](c1ccccc1)n1cncc1C(=O)Nc1ccc(Cl)cc1
Standard InChI: InChI=1S/C18H16ClN3O/c1-13(14-5-3-2-4-6-14)22-12-20-11-17(22)18(23)21-16-9-7-15(19)8-10-16/h2-13H,1H3,(H,21,23)/t13-/m1/s1
Standard InChI Key: NUAJLHJXZFBXQM-CYBMUJFWSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
32.5587 -0.7991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9356 -1.3418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1009 -2.1513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8805 -2.4192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5033 -1.8673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3390 -1.0597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2861 -2.1270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4504 -2.9354 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8938 -3.5411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2989 -4.2603 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.1082 -4.0944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1979 -3.2734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9145 -2.8616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6280 -3.2790 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.3446 -2.8671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0547 -3.2864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7708 -2.8754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7745 -2.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0561 -1.6364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3428 -2.0457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9047 -1.5827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9177 -2.0366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.4906 -1.6408 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
9 10 2 0
8 9 1 0
10 11 1 0
11 12 2 0
12 8 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
7 21 1 1
13 22 2 0
18 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 325.80 | Molecular Weight (Monoisotopic): 325.0982 | AlogP: 4.40 | #Rotatable Bonds: 4 |
Polar Surface Area: 46.92 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.52 | CX LogP: 3.84 | CX LogD: 3.84 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.77 | Np Likeness Score: -1.47 |
References
1. Zhao S,Li X,Wang L,Peng W,Ye W,Li W,Wang YD,Chen WD. (2021) Design, synthesis and evaluation of 1-benzyl-1H-imidazole-5-carboxamide derivatives as potent TGR5 agonists., 32 [PMID:33440321] [10.1016/j.bmc.2020.115972] |